Abstract: The invention concerns pharmaceutical formulations comprising solvent/detergent (S/D)-treated plasma and a glycosaminoglycan such as hyaluronic acid, and their use for treating diseases, particularly musculoskeletal diseases.
Type:
Grant
Filed:
September 26, 2013
Date of Patent:
October 4, 2022
Assignees:
Bone Therapeutics S.A, Enrico Bastianelli SPRL